Autoantibody response against NALP5/MATER in primary ovarian insufficiency and in autoimmune Addison's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 5, 2015, Pages 1941-1948

  Brozzetti, Annalisa ^a   Alimohammadi, Mohammad ^b,c   Morelli, Silvia ^a   Minarelli, Viviana ^a   Hallgren, Åsa ^c   Giordano, Roberta ^d   De Bellis, Annamaria ^e   Perniola, Roberto ^f   Kämpe, Olle ^b,c   Falorni, Alberto ^a   Italian Addison Network, ^g  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF TURIN   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f VITO FAZZI HOSPITAL   (Italy)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; INHIBIN; PROTEIN MATER; PROTEIN NALP5; UNCLASSIFIED DRUG; NALP5 PROTEIN, HUMAN;

ADDISON DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE ADDISON DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BINDING ASSAY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; IDIOPATHIC PREMATURE OVARIAN INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN SUBUNIT; STEROIDOGENIC CELL AUTOIMMUNE PREMATURE OVARIAN INSUFFICIENCY; BLOOD; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADDISON DISEASE; ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INHIBINS; MALE; MIDDLE AGED; PRIMARY OVARIAN INSUFFICIENCY; YOUNG ADULT;

EID: 84929319452     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3571     Document Type: Article

References (39)

1. Husebye ES, Allolio B, Arlt W, et al. Consensus statement on the diagnosis, treatment and follow-up o patients with primary adrenal insufficiency. J Intern Medicine. 2014;275:104-115.
2. Falorni A, Minarelli V, Morelli S. Therapy of adrenal insufficiency: an update. Endocrine. 2013;43:514-528.
3. Winqvist O, Karlsson FA, Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 1992;339:1559-1562.
4. Baumann-Antczak A, Wedlock N, Bednarek J, et al. Autoimmune Addison's disease and 21-hydroxylase. Lancet. 1992;340:429-430.
5. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23:327-364.
6. Falorni A, Nikoshkov A, Laureti S, et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 1995;80:2752-2755.
7. Falorni A, Laureti S, Nikoshkov A, et al. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin Exp Immunol. 1997;107:341-345.
8. Falorni A, Laureti S, Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am. 2002;31:369-389.
9. Falorni A, Brozzetti A, La Torre D, Tortoioli C, Gambelunghe G. The association of genetic polymorphisms and autoimmune Addison's disease. Exp Rev Clin Immunol. 2008;4:441-456.
10. Mitchell AL, Macarthur KD, Gan EH, et al. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohort. PLoS One. 2014;9:e88991.
11. Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83:1049-1055.
12. Perniola R. Expression of the autoimmune regulator gene and its relevance to the mechanisms of central and peripheral tolerance. Clin Dev Immunol. 2012;2012:207403.
13. Perniola R, Musco G. The biochemical and biophysical properties of the autoimmune regulator (AIRE) protein. Biochim Biophys Acta. 2014;1842:326-337.
14. Tuomi T, Björses P, Falorni A, et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 1996;81:1488-1494.
15. Gebre-Medhin G, Husebye ES, Gustafson J, et al. Cytochrome P450IA2 and aromatic l-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett. 1997;412:439-445.
16. Ekwall O, Sjöberg K, Mirakian R, Rorsman F, Kämpe O. Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type I. Lancet. 199;354:568.
17. Ekwall O, Hedstrand H, Haavik J, et al. Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2000;85:2944-2950.
18. Skoldberg F, Portela-Gomes GM, Grimelius L, et al. Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. J Clin Endocrinol Metab. 2004;88:1445-1452.
19. Meloni A, Furcas M, Cetani F, et al A. Autoantibodies against type I Interferons as an additional diagnostic criteria for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2008;93:4389-4397.
20. Alimohammadi M, Björklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018-1028.
21. Tong ZB, Bondy CA, Zhou J, Nelson LM. A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum Reprod. 2002;17:903-911.
22. Welt CK. Primary ovarian insufficiency: A more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68:499-509.
23. Nelson LM. Clinical practice: Primary ovarian insufficiency. N Engl J Med. 2009;360:606-614.
24. Bakalov VK, Anasti JN, Calis KA, et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril. 2005;84:958-965.
25. La Marca A, Brozzetti A, Sighinolfi G, Marzotti S, Volpe A, Falorni A. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol. 2010;22:277-282.
26. Falorni A, Laureti S, Candeloro P, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril. 2002;78:270-279.
27. Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen C. Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone receptor complex of bovine corpus luteum. J Clin Invest. 1989;84:1857-1865.
28. Ryan MM, Jones HR Jr. Myasthenia gravis and premature ovarian failure. Muscle Nerve. 2004;30:231-233.
29. Kelkar RL, Meherji PK, Kadam SS, Gupta SK, Nandedkar TD. Circulating autoantibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol. 2005;66:53-67.
30. Samy ET, Setiady YY, Ohno K, Pramoonjago P, Sharp C, Tung KSK. The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function. Immunol Rev. 2006;212:170-184.
31. Otsuka N, Tong ZB, Vanevski K, Tu W, Cheng MH, Nelson LM. Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of mater. Endocrinology. 2011;152:2465-2473.
32. Tong ZB, Nelson LM. A mouse gene encoding an oocyte antigen associated with premature ovarian failure. Endocrinology. 1999; 140:3720-3726.
33. Falorni A, Laureti S, De Bellis A, et al. Italian Addison Network Study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab. 2004;89:1598-1604.
34. Falorni A, Örtqvist E, Persson, Lernmark Å. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods. 1995;186:89-99.
35. Tuohy VK, Altuntas CZ. Autoimmunity and premature ovarian failure. Curr Opin Obstet Gynecol. 2007;19:366-369.
36. Altuntas CZ, Johnson JM, Tuohy VK. Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J Immunol. 2006;177:1988-1996.
37. Kemp EH, Habibullah M, Kluger N, et al. Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients. J Clin Endocrinol Metab. 2014;99:1064-1071.
38. Guerau-de-Arellano M, Martinic M, Benoist C, Mathis D. Neonatal tolerance revisited: a perinatal window for Aire control of autoimmunity. J Exp Med. 2009;206:1245-1252.
39. Zhang P, Dixon M, Zucchelli M, et al. Expression analysis of the NLRP gene family suggests a role in human preimplantation development. PLoS One. 2008;3:e2755.